Bey-Liing Mau M.D.
General Internal Medicine
Medical Team: Breast Cancer
Current Title
- Attending Physician, Division of General Internal Medicine, 2002-present
Specialties
- General internal medicine
Clinical Interests
- General internal medicine
- Preventive medicine
- Women's health
Languages Spoken
Education and Training
1977-1984 |
Kaohsiung Medical School, Taiwan, MD, Medicine |
1986-1991 |
Mayo Graduate School, Rochester, MN, USA, PhD, Pharmacology |
1992-1993 |
Internship, University of Tennessee, Memphis, TN, USA |
1993-1995 |
Residency, University of Tennessee, Memphis, TN, USA |
Professional Experience
3/1996-9/1998 |
Physician, Internal Medicine, Methodist Primary Care Association, USA |
11/1999-7/2002 |
Director of Clinical Division, Center for Drug Evaluation, Taiwan |
7/2002-present |
Attending Physician, Internal Medicine, Koo Foundation Sun Yat-Sen Cancer Center, Taiwan |
Professional Memberships
- Member, Taiwan Society of Internal Medicine
Selected Publications
- Mau B.-L. and Powis, G.: Mechanism-based inhibition of thioredoxin reductase by antitumor quinoid compounds.
Biochem Pharmacol (England) 43: 1613-1620, 1992.
- Mau B.-L. and Powis, G.: Inhibition of cellular thioredoxin reductase by diaziquone and doxorubicin Relationship to the inhibition of cell proliferation and decreased ribonucleotide reductase activity.
Biochem Pharmacol (England), 43: 1621-1627, 1992.
- Lin YL, Mau BL, Chern HD, Chu ML. What type of pivotal study design is appropriate for an investigational drug to manage chronic angle closure glaucoma?
Drug Info J 36; 499-500, 2002.
- Yeong-Liang Lin, MD, chia-Hsin Huang, MD, Chih-Liu Lin, MD, and Bey-Liing Mau, MD, PHD, Compliance of clinical trial consent forms with international guidelines: Analysis of deficiencies.
Drug Info J 36: 17-19, 2002
- Tzen C-Y and Mau B-L: Analysis of CD117-Negative Gastrointestinal Stromal Tumors.
World J Gastroenterol 11: 1052-1055, 2005
- Mau B-L, Lee H-M, and Tzen C-Y: Identification of Human-specific Adaptation Sites of ATP6.
AnnuNYAcad Sci1042: 142-147, 2005
- C-Y Tzen, B-L Mau, Y-W Huang, M-J Huang and C-P Chen: Is extramedullary plasmacytoma an oligoclonal tumor with clonal selection during tumor progression?
Histopathology 48:463-477, 2006
- Tzen C-Y, Mau B-L, and Hsu H-J: Analysis of disease-associated ND4 mutations: How do we know which mutation is pathogenic?
Mitochondrion7:151-156, 2007
- Tzen C-Y, Mau B-L, and Wu T-Y: ND4 mutation in transitional cell carcinoma: Does mitochondrial mutation occur before tumorigenesis?
Mitochondrion7:273-278, 2007
- Tzen C-Y, Wang M-N, and Mau B-L: Spectrum and Prognostication of KIT and PDGFRA Mutation in Gastrointestinal Stromal Tumors.
Eur J Surg Oncol 34:563-568, 2008.
- Lai Y-L, Mau B-L, Cheng W-H, Chen H-M, Chiu H-H, and Tzen C-Y: PIK3CA Exon 20 Mutation is Independently Associated with a Poor Prognosis in Breast Cancer Patients.
Ann Surg Oncol15:1064-1069, 2008
- Mau B-L, Huang Y-W, Wu C-Y, and Tzen C-Y: Diffuse Large B Cell Lymphomas in the Intestine and Lung: Two Lymphomas or Lymphoma Spread?
Clin Mol Med 1: 30-32, 2008
- 褚乃銘、毛蓓領:專家對談-侵襲性乳癌之標靶治療。生物醫學2008;1:153-157。
- 毛蓓領:乳癌療法的回顧與分子指標。生物醫學2009;2:162-172。
- 毛蓓領:專家評論-糖尿病的藥物治療。生物醫學2010;3:369-373。
- 毛蓓領:胃腸胰神經內分泌瘤的症狀與治療。生物醫學2011;4:43-56。